|
1
|
Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
|
Chem Biol
|
2005
|
2.05
|
|
2
|
Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
|
J Med Chem
|
2005
|
1.80
|
|
3
|
Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.
|
Chem Commun (Camb)
|
2005
|
1.58
|
|
4
|
HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.
|
Bioconjug Chem
|
2006
|
1.36
|
|
5
|
Dendrimer-epidermal growth factor conjugate displays superagonist activity.
|
Biomacromolecules
|
2008
|
1.31
|
|
6
|
Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.
|
Int J Nanomedicine
|
2008
|
1.28
|
|
7
|
Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic Acid-conjugated dendrimers.
|
ACS Nano
|
2008
|
1.22
|
|
8
|
Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles.
|
Phys Chem Chem Phys
|
2007
|
1.20
|
|
9
|
Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate.
|
Chem Commun (Camb)
|
2010
|
1.04
|
|
10
|
Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations.
|
Biomacromolecules
|
2009
|
1.03
|
|
11
|
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis.
|
Arthritis Rheum
|
2011
|
1.03
|
|
12
|
Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
|
Anticancer Drugs
|
2008
|
0.97
|
|
13
|
Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery.
|
Bioorg Med Chem Lett
|
2010
|
0.94
|
|
14
|
HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb.
|
Nanotechnology
|
2008
|
0.94
|
|
15
|
Detection and analysis of tumor fluorescence using a two-photon optical fiber probe.
|
Biophys J
|
2004
|
0.93
|
|
16
|
Fiber-optic multiphoton flow cytometry in whole blood and in vivo.
|
J Biomed Opt
|
2010
|
0.91
|
|
17
|
Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting.
|
Eur J Med Chem
|
2011
|
0.91
|
|
18
|
Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.
|
Photochem Photobiol Sci
|
2012
|
0.91
|
|
19
|
Investigation of tumor cell targeting of a dendrimer nanoparticle using a double-clad optical fiber probe.
|
J Biomed Opt
|
2008
|
0.90
|
|
20
|
Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
|
Biomacromolecules
|
2012
|
0.90
|
|
21
|
Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles.
|
ACS Chem Biol
|
2013
|
0.87
|
|
22
|
Dendrimer-based multivalent vancomycin nanoplatform for targeting the drug-resistant bacterial surface.
|
ACS Nano
|
2012
|
0.87
|
|
23
|
Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.
|
Bioconjug Chem
|
2011
|
0.86
|
|
24
|
Dendrimer-based tumor cell targeting of fibroblast growth factor-1.
|
Bioorg Med Chem Lett
|
2009
|
0.86
|
|
25
|
Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs.
|
Bioorg Med Chem Lett
|
2009
|
0.83
|
|
26
|
Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
|
Bioorg Med Chem
|
2011
|
0.82
|
|
27
|
Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.
|
Curr Pharm Des
|
2013
|
0.80
|
|
28
|
PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic.
|
Biomacromolecules
|
2014
|
0.80
|
|
29
|
Specific and cooperative interactions between oximes and PAMAM dendrimers as demonstrated by (1)H NMR study.
|
J Phys Chem B
|
2012
|
0.78
|
|
30
|
Optical fiber-based in vivo quantification of growth factor receptors.
|
Cancer
|
2011
|
0.77
|
|
31
|
Connective tissue activation XXXVIII: heparin/heparanase activity of human platelets resides in a high molecular weight protein, not in connective tissue activating peptide III.
|
J Rheumatol
|
2002
|
0.76
|
|
32
|
Plasma-mediated release of morphine from synthesized prodrugs.
|
Bioorg Med Chem Lett
|
2010
|
0.75
|
|
33
|
Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
|
J Biomed Nanotechnol
|
2015
|
0.75
|